Emtora Biosciences: Emtora Awarded $16.9M Grant from the Cancer Prevention & Research Institute of Texas

Emtora Biosciences announced it has been awarded a $16.9M non-dilutive grant from the Cancer Prevention & Research Institute of Texas to advance the clinical and product development of its lead program, eRapaTM, an encapsulated form of rapamycin, for the treatment of Familial Adenomatous Polyposis.